06/04/2026
The FDA has scheduled a Pharmacy Compounding Advisory Committee meeting for July 23–24 to discuss several peptide substances and their future status within compounding.
This is not an approval announcement, and no final decisions have been made.
But it is one of the most important peptide-related discussions we've seen in a long time, which is why so many people are paying attention.
What do you think this could mean for the future of peptide access?
👇 Let me know in the comments.